Faezeh Rouhi
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Faezeh Rouhi has a total of 34 co-authors. Here are the top co-authors by number of shared publications:
- Hossein Mirhendi
Department of Medical Parasitology and Mycology, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran
6 shared publications Mahzad Erami
Department of Infectious Disease, School of Medicine, Infectious Diseases Research Center, Kashan University of Medical Sciences, Kashan, Iran
5 shared publicationsShima Aboutalebian
Department of Medical Parasitology and Mycology, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran
5 shared publicationsSajedeh Soltani
Department of Medical Parasitology and Mycology, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran
4 shared publicationsHamed Fakhim
Infectious Diseases and Tropical Medicine Research Center, Isfahan University of Medical Sciences, Isfahan, Iran
3 shared publicationsShahla Shadzi
Department of Medical Parasitology and Mycology, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran
3 shared publications
Latest Publications
- 26 September 2025
- Published by Springer Nature in European Journal of Clinical Microbiology & Infectious Diseases
- Vol. 44 (12) , 3029-3035
Update on the epidemiology of dermatophytosis in Isfahan, Iran over the past decade
Background Dermatophytes, keratinolytic fungi causing tinea (ringworm), are a major global cause of skin infections, affecting 20–25% of the population. This study updates the epidemiological profile of dermatophytosis in Isfahan, Iran, from 2013 to 2023, focusing on prevalence, and species distribution. Methods This retrospective study analyzed 22,198 clinical samples from 2013 to 2023 at a reference medical mycology laboratory in Isfahan, Iran. Patient data, including demographics and infection sites, were recorded. Samples from skin, nails, and hair were examined using KOH direct microscopy and cultured on Sabouraud agar media with chloramphenicol and cycloheximide. Results Over the decade, 22,198 clinical samples were analysed, of which 5,038 (22.7%) were confirmed by microscopy as dermatophytosis. Tinea corporis (22.79%) and tinea capitis (21.3%) were the most prevalent infections. Most cases occurred in females (58.57%) and individuals aged 41–50 years. High-risk groups included housewives, farmers, and livestock handlers. Among 770 cultured samples, Trichophyton mentagrophytes complex was the most common species. Conclusion This study provides valuable insights into the epidemiology and clinical trends of dermatophytosis in Isfahan, Iran, over the past decade. Among the cultured cases, the T. mentagrophytes complex was the most frequently isolated species, suggesting a possible shift in the causative agents of tinea infections. However, since most confirmed cases were not cultured, the species distribution in the broader population remains uncertain. Further research using molecular identification and investigation of environmental factors will help improve our understanding and management of these infections.
- 26 September 2025
- Published by Springer Nature in European Journal of Clinical Microbiology & Infectious Diseases
- Vol. 44 (12) , 3029-3035
Update on the epidemiology of dermatophytosis in Isfahan, Iran over the past decade
Background Dermatophytes, keratinolytic fungi causing tinea (ringworm), are a major global cause of skin infections, affecting 20–25% of the population. This study updates the epidemiological profile of dermatophytosis in Isfahan, Iran, from 2013 to 2023, focusing on prevalence, and species distribution. Methods This retrospective study analyzed 22,198 clinical samples from 2013 to 2023 at a reference medical mycology laboratory in Isfahan, Iran. Patient data, including demographics and infection sites, were recorded. Samples from skin, nails, and hair were examined using KOH direct microscopy and cultured on Sabouraud agar media with chloramphenicol and cycloheximide. Results Over the decade, 22,198 clinical samples were analysed, of which 5,038 (22.7%) were confirmed by microscopy as dermatophytosis. Tinea corporis (22.79%) and tinea capitis (21.3%) were the most prevalent infections. Most cases occurred in females (58.57%) and individuals aged 41–50 years. High-risk groups included housewives, farmers, and livestock handlers. Among 770 cultured samples, Trichophyton mentagrophytes complex was the most common species. Conclusion This study provides valuable insights into the epidemiology and clinical trends of dermatophytosis in Isfahan, Iran, over the past decade. Among the cultured cases, the T. mentagrophytes complex was the most frequently isolated species, suggesting a possible shift in the causative agents of tinea infections. However, since most confirmed cases were not cultured, the species distribution in the broader population remains uncertain. Further research using molecular identification and investigation of environmental factors will help improve our understanding and management of these infections.
- 5 March 2025
- Published by Springer Nature in Mycopathologia
- Vol. 190 (2) , 1-13
Molecular Assays Versus Mycological Methods for Diagnosis of Rhino Orbital Mucormycosis: Analysis of 120 Clinical Specimens from COVID-19 Patients
Background Mucormycosis, a fungal emergency, poses a serious threat to both COVID-19 and non-COVID-19 individuals due to its invasive nature, rapid progression, and high rates of morbidity and mortality. This underscores the crucial need for timely detection and management. In this study, we investigated the utility of real-time PCR (RT-qPCR) assays for detecting Mucorales in clinical specimens, and assessed the performance of both SYBR Green and TaqMan probe RT-qPCR in amplifying Mucorales-specific 18S rDNA genes. We conducted accuracy analyses using direct examination with KOH as a standard for the laboratory diagnosis of mucormycosis. Additionally, we compared the results with culture and duplex PCR. Patients/Methods Both SYBR Green and TaqMan RT-qPCR were optimized using Mucorales-specific oligonucleotides to amplify the conserved 18S rDNA targets. DNAs extracted from 120 rhino sinus specimens, which all were collected from COVID-19 patients upon suspicion of invasive fungal infections, were used for molecular diagnosis. The results of both RT-qPCR assays were compared with the result of direct microscopy, culture, and duplex Mucorales-specific PCR assay. Results SYBR Green real-time PCR produced a distinct melting temperature (Tm) pattern (80.24 ± 0.70 °C) and detected Mucorales in 51 out of 120 clinical samples. When compared to direct examination with KOH, the standard method for diagnosing mucormycosis, SYBR Green PCR demonstrated a sensitivity of 91.67% (95% confidence interval (CI): 86.7–96.5%) and a specificity of 90.28% (95% CI: 84.9–95.5%). In contrast, TaqMan-probe PCR identified Mucorales in 34 out of 120 samples, with a sensitivity of 64.58% (95% CI: 56–73.1%) and a specificity of 95.83% (95% CI: 92.26–99.39%). Conclusion SYBR Green-based PCR can be used as a reliable confirmatory test for diagnosing mucormycosis, particularly in cases with atypical hyphae, mixed infections (featuring both septate and non-septate hyphae), or when the direct examination is positive but culture results are negative. The lower sensitivity of the TaqMan-probe PCR may be attributed to factors such as using a degenerate probe, which can lead to false-negative results.
- 5 March 2025
- Published by Springer Nature in Mycopathologia
- Vol. 190 (2) , 1-13
Molecular Assays Versus Mycological Methods for Diagnosis of Rhino Orbital Mucormycosis: Analysis of 120 Clinical Specimens from COVID-19 Patients
Background Mucormycosis, a fungal emergency, poses a serious threat to both COVID-19 and non-COVID-19 individuals due to its invasive nature, rapid progression, and high rates of morbidity and mortality. This underscores the crucial need for timely detection and management. In this study, we investigated the utility of real-time PCR (RT-qPCR) assays for detecting Mucorales in clinical specimens, and assessed the performance of both SYBR Green and TaqMan probe RT-qPCR in amplifying Mucorales-specific 18S rDNA genes. We conducted accuracy analyses using direct examination with KOH as a standard for the laboratory diagnosis of mucormycosis. Additionally, we compared the results with culture and duplex PCR. Patients/Methods Both SYBR Green and TaqMan RT-qPCR were optimized using Mucorales-specific oligonucleotides to amplify the conserved 18S rDNA targets. DNAs extracted from 120 rhino sinus specimens, which all were collected from COVID-19 patients upon suspicion of invasive fungal infections, were used for molecular diagnosis. The results of both RT-qPCR assays were compared with the result of direct microscopy, culture, and duplex Mucorales-specific PCR assay. Results SYBR Green real-time PCR produced a distinct melting temperature (Tm) pattern (80.24 ± 0.70 °C) and detected Mucorales in 51 out of 120 clinical samples. When compared to direct examination with KOH, the standard method for diagnosing mucormycosis, SYBR Green PCR demonstrated a sensitivity of 91.67% (95% confidence interval (CI): 86.7–96.5%) and a specificity of 90.28% (95% CI: 84.9–95.5%). In contrast, TaqMan-probe PCR identified Mucorales in 34 out of 120 samples, with a sensitivity of 64.58% (95% CI: 56–73.1%) and a specificity of 95.83% (95% CI: 92.26–99.39%). Conclusion SYBR Green-based PCR can be used as a reliable confirmatory test for diagnosing mucormycosis, particularly in cases with atypical hyphae, mixed infections (featuring both septate and non-septate hyphae), or when the direct examination is positive but culture results are negative. The lower sensitivity of the TaqMan-probe PCR may be attributed to factors such as using a degenerate probe, which can lead to false-negative results.
- Open Access
- 5 February 2025
- Published by Elsevier in Biochemistry and Biophysics Reports
- Vol. 41, 101931
Apoptosis-inducing proteins with reduced expression in breast cancer: A review article
- 5 February 2025
- Published by Elsevier in Biochemistry and Biophysics Reports
- Vol. 41, 101931
Open AccessApoptosis-inducing proteins with reduced expression in breast cancer: A review article
Development and Evaluation of SYBR Green Real‐Time PCR for Rapid and Specific Identification of Trichophyton indotineae
Background: Since 2017, dermatophytosis caused by the newly introduced species Trichophyton indotineae has gained new interest worldwide due to the rise in terbinafine resistance and difficulty in the treatment of recalcitrant infections. Distinguishing T. indotineae from other Trichophyton species based on morphological features is impossible and DNA sequencing is necessary for accurate identification. Though early identification of the species is not solely sufficient for the treatment of infected cases, it is important for clinicians to take the next appropriate modalities such as antifungal susceptibility testing especially when the patients have extensive skin lesions recalcitrant to therapy by terbinafine. Here, we developed a rapid diagnostic scheme using SYBR Green real‐time PCR for the specific detection/identification of T. indotineae.Methods: DNA was extracted from 397 dermatophyte isolates and two SYBR Green real‐time PCR assays targeting the C120‐287 and E054‐58 intergenic loci were developed. Using a collection of 132 T. indotineae and 128 non‐T. indotineae strains, all had already been identified by ITS‐PCR‐sequencing and 137 unknown dermatophyte isolates, the assays were evaluated.Results: In both real‐time PCR assays, 130 out of 132 T. indotineae strains were positive while all non‐T. indotineae species were negative. Among 137 unknown tested isolates, 72 were identified as T. indotineae based on two real‐time PCR assays, while 65 showed no peak and were considered non‐T. indotineae. Based on PCR‐sequencing as the reference standard, the SYBR Green real‐time PCR assays demonstrated a sensitivity of 98.48% and a specificity of 100%.Conclusion: The developed diagnostic assays using SYBR Green real‐time PCR provided a rapid and accurate method for the distinction of cultured T. indotineae isolates and can be considered to evaluate for the detection of T. indotineae directly from clinical samples.
Development and Evaluation of SYBR Green Real‐Time PCR for Rapid and Specific Identification of Trichophyton indotineae
Background: Since 2017, dermatophytosis caused by the newly introduced species Trichophyton indotineae has gained new interest worldwide due to the rise in terbinafine resistance and difficulty in the treatment of recalcitrant infections. Distinguishing T. indotineae from other Trichophyton species based on morphological features is impossible and DNA sequencing is necessary for accurate identification. Though early identification of the species is not solely sufficient for the treatment of infected cases, it is important for clinicians to take the next appropriate modalities such as antifungal susceptibility testing especially when the patients have extensive skin lesions recalcitrant to therapy by terbinafine. Here, we developed a rapid diagnostic scheme using SYBR Green real‐time PCR for the specific detection/identification of T. indotineae.Methods: DNA was extracted from 397 dermatophyte isolates and two SYBR Green real‐time PCR assays targeting the C120‐287 and E054‐58 intergenic loci were developed. Using a collection of 132 T. indotineae and 128 non‐T. indotineae strains, all had already been identified by ITS‐PCR‐sequencing and 137 unknown dermatophyte isolates, the assays were evaluated.Results: In both real‐time PCR assays, 130 out of 132 T. indotineae strains were positive while all non‐T. indotineae species were negative. Among 137 unknown tested isolates, 72 were identified as T. indotineae based on two real‐time PCR assays, while 65 showed no peak and were considered non‐T. indotineae. Based on PCR‐sequencing as the reference standard, the SYBR Green real‐time PCR assays demonstrated a sensitivity of 98.48% and a specificity of 100%.Conclusion: The developed diagnostic assays using SYBR Green real‐time PCR provided a rapid and accurate method for the distinction of cultured T. indotineae isolates and can be considered to evaluate for the detection of T. indotineae directly from clinical samples.
Increasing and Alarming Prevalence of Trichophyton indotineae as the Primary Causal Agent of Skin Dermatophytosis in Iran
Background: Trichophyton indotineae, formerly described as T. mentagrophytes rDNA‐ITS genotype VIII, has recently been identified as a novel species within the T. mentagrophytes complex. It has rapidly replaced T. rubrum as the predominant dermatophyte. In this study, skin dermatophyte isolates collected from patients in Iran were sequence‐analysed for species identification. Additionally, the current prevalence of T. indotineae was compared with data from the previous decade.Methods: A total of 194 dermatophyte isolates were collected from patients in four cities across Iran between July and December 2023, with 73 isolates of the T. mentagrophytes complex from the past decade also included. DNA was extracted from fresh colonies, and the internal transcribed spacer (ITS) 1–5.8S rDNA‐ITS2 region was PCR‐amplified and sequenced, followed by bioinformatic sequence analysis.Results: Out of the 194 dermatophyte isolates, 132 samples (68.04%) were identified as T. indotineae, followed by T. tonsurans (14.43%), T. rubrum (7.22%), Microsporum canis (4.64%), T. interdigitale (3.61%), T. mentagrophytes (1.55%) and Arthroderma benhamiae (0.51%). Sequence analysis of 73 isolates from the past decade showed T. indotineae as the most frequently identified species (43.83%), followed by T. interdigitale (32.88%), T. mentagrophytes (21.92%) and Nannizzia fulva (1.37%). These findings indicate an increasing prevalence of T. indotineae in Iran in recent years. We analysed 214 T. mentagrophytes/T. interdigitale isolates, identifying 164 as T. indotineae, including 26 with nucleotide variations. A phylogenetic tree highlighted the genetic diversity within the species complex.Conclusion: The alarmingly high prevalence of the potentially drug‐resistant species T. indotineae signals the necessity of continuous surveillance of skin dermatophytosis in the community.
Increasing and Alarming Prevalence of Trichophyton indotineae as the Primary Causal Agent of Skin Dermatophytosis in Iran
Background: Trichophyton indotineae, formerly described as T. mentagrophytes rDNA‐ITS genotype VIII, has recently been identified as a novel species within the T. mentagrophytes complex. It has rapidly replaced T. rubrum as the predominant dermatophyte. In this study, skin dermatophyte isolates collected from patients in Iran were sequence‐analysed for species identification. Additionally, the current prevalence of T. indotineae was compared with data from the previous decade.Methods: A total of 194 dermatophyte isolates were collected from patients in four cities across Iran between July and December 2023, with 73 isolates of the T. mentagrophytes complex from the past decade also included. DNA was extracted from fresh colonies, and the internal transcribed spacer (ITS) 1–5.8S rDNA‐ITS2 region was PCR‐amplified and sequenced, followed by bioinformatic sequence analysis.Results: Out of the 194 dermatophyte isolates, 132 samples (68.04%) were identified as T. indotineae, followed by T. tonsurans (14.43%), T. rubrum (7.22%), Microsporum canis (4.64%), T. interdigitale (3.61%), T. mentagrophytes (1.55%) and Arthroderma benhamiae (0.51%). Sequence analysis of 73 isolates from the past decade showed T. indotineae as the most frequently identified species (43.83%), followed by T. interdigitale (32.88%), T. mentagrophytes (21.92%) and Nannizzia fulva (1.37%). These findings indicate an increasing prevalence of T. indotineae in Iran in recent years. We analysed 214 T. mentagrophytes/T. interdigitale isolates, identifying 164 as T. indotineae, including 26 with nucleotide variations. A phylogenetic tree highlighted the genetic diversity within the species complex.Conclusion: The alarmingly high prevalence of the potentially drug‐resistant species T. indotineae signals the necessity of continuous surveillance of skin dermatophytosis in the community.
- Open Access
- 24 September 2024
- Published by Frontiers Media SA in Frontiers in Cellular and Infection Microbiology
- Vol. 14, 1426200
Quantitative real time PCR for distinction between Pneumocystis jirovecii infection/colonization in hospitalized patients
Background: Identification of the opportunistic fungus Pneumocystis jirovecii in respiratory specimens presents challenges, particularly in differentiating between colonization and active infection. The present study assessed a probe-based real time PCR (qPCR) diagnostic effectiveness in patients with diverse underlying conditions, particularly those with COVID-19 and pulmonary insufficiency.Methods: To set up the qPCR, clinical samples from 281 patients with respiratory ailments were tested. Subsequently, a descriptive study was conducted on 112 patients with pulmonary insufficiency with and without COVID-19 suspected of P. jirovecii infection. All specimens were subjected to DNA extraction followed by nested PCR and qPCR targeting the mitochondrial large subunit (mtLSU)-rRNA gene.Results: Based on nested PCR and qPCR, P. jirovecii was identified in 40 out of 281 patients, with slight variations in positive samples observed across dilutions. Three patients who tested positive in nested PCR yielded negative results in probe-based qPCR. Conversely, three patients who tested positive in probe-based qPCR yielded negative results in nested PCR. Considering nested PCR as the golden standard, probe-based qPCR demonstrated good diagnostic performance, with 92.5% sensitivity and 98.7% specificity. Based on cycle threshold (Ct) values, the positive cases were categorized: ≤32 as infection, >35 as colonization, and a grey zone between these values (32 < X ≤ 35). The analysis of 112 PCP-suspected patients revealed a prevalence ranging from 6.25% (nested PCR) to 7% (probe-based qPCR).Conclusions: This study suggested Ct values to differentiate Pneumocystis pneumonia/colonization in immunocompromised patients. To further augment the diagnostic sensitivity, it is recommended to integrate qPCR results with clinical parameters and biomarkers to offer a more precise understanding of Pneumocystis-related conditions.
- 24 September 2024
- Published by Frontiers Media SA in Frontiers in Cellular and Infection Microbiology
- Vol. 14, 1426200
Open AccessQuantitative real time PCR for distinction between Pneumocystis jirovecii infection/colonization in hospitalized patients
Background: Identification of the opportunistic fungus Pneumocystis jirovecii in respiratory specimens presents challenges, particularly in differentiating between colonization and active infection. The present study assessed a probe-based real time PCR (qPCR) diagnostic effectiveness in patients with diverse underlying conditions, particularly those with COVID-19 and pulmonary insufficiency.Methods: To set up the qPCR, clinical samples from 281 patients with respiratory ailments were tested. Subsequently, a descriptive study was conducted on 112 patients with pulmonary insufficiency with and without COVID-19 suspected of P. jirovecii infection. All specimens were subjected to DNA extraction followed by nested PCR and qPCR targeting the mitochondrial large subunit (mtLSU)-rRNA gene.Results: Based on nested PCR and qPCR, P. jirovecii was identified in 40 out of 281 patients, with slight variations in positive samples observed across dilutions. Three patients who tested positive in nested PCR yielded negative results in probe-based qPCR. Conversely, three patients who tested positive in probe-based qPCR yielded negative results in nested PCR. Considering nested PCR as the golden standard, probe-based qPCR demonstrated good diagnostic performance, with 92.5% sensitivity and 98.7% specificity. Based on cycle threshold (Ct) values, the positive cases were categorized: ≤32 as infection, >35 as colonization, and a grey zone between these values (32 < X ≤ 35). The analysis of 112 PCP-suspected patients revealed a prevalence ranging from 6.25% (nested PCR) to 7% (probe-based qPCR).Conclusions: This study suggested Ct values to differentiate Pneumocystis pneumonia/colonization in immunocompromised patients. To further augment the diagnostic sensitivity, it is recommended to integrate qPCR results with clinical parameters and biomarkers to offer a more precise understanding of Pneumocystis-related conditions.
- Open Access
- 19 July 2024
- Published by Springer Nature in Research Square
Molecular assays versus mycological methods for diagnosis of rhino orbital mucormycosis: analysis of 120 fresh clinical specimens from COVID-19 patients
Mucormycosis, a fungal emergency, poses a serious threat to both COVID-19 and non-COVID-19 individuals due to its invasive nature, rapid progression, and high rates of morbidity and mortality which highlights the crucial need for its timely detection and management. Here, we investigated the utility of Mucorales-specific real-time PCR (rt-PCR) assays for the detection of mucormycosis from clinical specimens and compared with conventional methods and duplex PCR. Methods: Both SYBR Green and TaqMan rt-PCR methodologies were optimized using Mucorales-specific oligonucleotides to amplify the conserved 18S rDNA targets. DNAs extracted from 120 rhino sinus specimens, which all were collected from COVID-19 patients upon suspicion of invasive fungal infections, were used for molecular diagnosis. The results of both rt PCR assays were compared with the result of direct microscopy, culture, and duplex Mucorales-specific PCR assay. Results: SYBR Green rt-PCR detected Mucorales in 51 out of 120 (91.67% of K0H-positive samples), yielding a unique Tm pattern (80.24 ± 0.70°C), whereas TaqMan-probe PCR and culture methods detected it in 34 (73.84%) and 24 samples, respectively. The SYBR Green-based PCR was also more sensitive/specific than the duplex PCR technique. The lower sensitivity in probe-based PCR can be influenced by various factors such as probe degeneracy, which can lead to false-negative results. Conclusion: SYBR Green-based PCR showed superiority over duplex PCR, culture, and TaqMan-probe PCR in terms of cost-effectiveness, rapidness, and sensitivity for the diagnosis of mucormycosis. As there is no serological test, SYBR Green-based PCR can be used as an affirmatory test to rule in or rule out mucormycosis, particularly in cases with atypical hyphae or septate and non-septate hyphae suggestive of mixed infections in direct examination but negative culture.
- 19 July 2024
- Published by Springer Nature in Research Square
Open AccessMolecular assays versus mycological methods for diagnosis of rhino orbital mucormycosis: analysis of 120 fresh clinical specimens from COVID-19 patients
Mucormycosis, a fungal emergency, poses a serious threat to both COVID-19 and non-COVID-19 individuals due to its invasive nature, rapid progression, and high rates of morbidity and mortality which highlights the crucial need for its timely detection and management. Here, we investigated the utility of Mucorales-specific real-time PCR (rt-PCR) assays for the detection of mucormycosis from clinical specimens and compared with conventional methods and duplex PCR. Methods: Both SYBR Green and TaqMan rt-PCR methodologies were optimized using Mucorales-specific oligonucleotides to amplify the conserved 18S rDNA targets. DNAs extracted from 120 rhino sinus specimens, which all were collected from COVID-19 patients upon suspicion of invasive fungal infections, were used for molecular diagnosis. The results of both rt PCR assays were compared with the result of direct microscopy, culture, and duplex Mucorales-specific PCR assay. Results: SYBR Green rt-PCR detected Mucorales in 51 out of 120 (91.67% of K0H-positive samples), yielding a unique Tm pattern (80.24 ± 0.70°C), whereas TaqMan-probe PCR and culture methods detected it in 34 (73.84%) and 24 samples, respectively. The SYBR Green-based PCR was also more sensitive/specific than the duplex PCR technique. The lower sensitivity in probe-based PCR can be influenced by various factors such as probe degeneracy, which can lead to false-negative results. Conclusion: SYBR Green-based PCR showed superiority over duplex PCR, culture, and TaqMan-probe PCR in terms of cost-effectiveness, rapidness, and sensitivity for the diagnosis of mucormycosis. As there is no serological test, SYBR Green-based PCR can be used as an affirmatory test to rule in or rule out mucormycosis, particularly in cases with atypical hyphae or septate and non-septate hyphae suggestive of mixed infections in direct examination but negative culture.
- Open Access
- 19 April 2024
- Published by Frontiers Media SA in Frontiers in Cellular and Infection Microbiology
- Vol. 14, 1295841
Yeast species in the respiratory samples of COVID-19 patients; molecular tracking of Candida auris
Introduction: Although the existence of Candida species in the respiratory tract is often considered commensal, it is crucial to recognize the significance of Candida colonization in immunocompromised or COVID-19 patients. The emergence of Candida auris as an emerging pathogen further emphasizes the importance of monitoring yeast infection/colonization, particularly in COVID-19 patients.Methods: In this study, respiratory samples mainly from COVID-19 patients, primarily those suspected of having a fungal infection, were cultured on Sabouraud dextrose agar plates and the yeast colonies were identified using a two-step multiplex PCR method. The samples suspected of C. auris underwent specific nested PCR followed by sequence analysis.Results: A total of 199 respiratory samples were collected from 73 women and 126 men, ranging in age from 1.6 to 88 years. Among the patients, 141 had COVID-19, 32 had cancer, 5 were hospitalized in ICU, 2 had chronic obstructive pulmonary disease)COPD(, and others were patients with combination diseases. From these samples, a total of 334 yeast strains were identified. C. albicans (n=132, 39.52%) was the most common species, followed by C. tropicalis (n=67, 20%), C. glabrata (n=56, 16.76%), C. krusei (n=18, 5.4%), C. parapsilosis (n=17, 5.08%), Saccharomyces cerevisiae (n=10, 3%), C. kefyr (n=9, 2.6%), C. dubliniensis (n=7, 2.1%), C. lusitaniae (n=5, 1.5%), C. auris (n=3, 0.9%), C. guilliermondii (n=2, 0.6%), C. rugosa (n=1, 0.3%), C. intermedia (n=1, 0.3%), and Trichosporon spp. (n=1, 0.3%). C. auris was detected in a patient in ICU and two COVID-19 patients. While its presence was confirmed through sequence analysis, our extensive efforts to isolate C. auris were unsuccessful.Conclusion: While C. albicans colonization remains prevalent, our study found no evidence of Candida lung infection. Since the role of Candida colonization in airway secretions remains ambiguous due to limited research, further studies are imperative to shed light on this matter.
- 19 April 2024
- Published by Frontiers Media SA in Frontiers in Cellular and Infection Microbiology
- Vol. 14, 1295841
Open AccessYeast species in the respiratory samples of COVID-19 patients; molecular tracking of Candida auris
Introduction: Although the existence of Candida species in the respiratory tract is often considered commensal, it is crucial to recognize the significance of Candida colonization in immunocompromised or COVID-19 patients. The emergence of Candida auris as an emerging pathogen further emphasizes the importance of monitoring yeast infection/colonization, particularly in COVID-19 patients.Methods: In this study, respiratory samples mainly from COVID-19 patients, primarily those suspected of having a fungal infection, were cultured on Sabouraud dextrose agar plates and the yeast colonies were identified using a two-step multiplex PCR method. The samples suspected of C. auris underwent specific nested PCR followed by sequence analysis.Results: A total of 199 respiratory samples were collected from 73 women and 126 men, ranging in age from 1.6 to 88 years. Among the patients, 141 had COVID-19, 32 had cancer, 5 were hospitalized in ICU, 2 had chronic obstructive pulmonary disease)COPD(, and others were patients with combination diseases. From these samples, a total of 334 yeast strains were identified. C. albicans (n=132, 39.52%) was the most common species, followed by C. tropicalis (n=67, 20%), C. glabrata (n=56, 16.76%), C. krusei (n=18, 5.4%), C. parapsilosis (n=17, 5.08%), Saccharomyces cerevisiae (n=10, 3%), C. kefyr (n=9, 2.6%), C. dubliniensis (n=7, 2.1%), C. lusitaniae (n=5, 1.5%), C. auris (n=3, 0.9%), C. guilliermondii (n=2, 0.6%), C. rugosa (n=1, 0.3%), C. intermedia (n=1, 0.3%), and Trichosporon spp. (n=1, 0.3%). C. auris was detected in a patient in ICU and two COVID-19 patients. While its presence was confirmed through sequence analysis, our extensive efforts to isolate C. auris were unsuccessful.Conclusion: While C. albicans colonization remains prevalent, our study found no evidence of Candida lung infection. Since the role of Candida colonization in airway secretions remains ambiguous due to limited research, further studies are imperative to shed light on this matter.
- Open Access
- 6 April 2023
- Published by Frontiers Media SA in Frontiers in Medicine
- Vol. 10, 1148320
Molecular and microscopy detection of Pneumocystis jirovecii in hospitalized patients during the COVID-19 pandemic
Introduction: Early detection of Pneumocystis jirovecii as an opportunistic pathogen that may endanger predisposed persons, including COVID-19 patients, may help to choose the optimal management.Methods: In this study, 585, including 530 COVID-19 patients, with clinical and radiological evidence of respiratory diseases, were investigated for P. jirovecii screening. Clinical specimens were examined by direct microscopy and PCR, and randomly selected positive PCR products were confirmed through DNA sequence analysis.Results: Thirty-one (5.3%) samples were positive in P. jirovecii-specific nested-PCR, while by direct microscopic tests, Pneumocystis was observed in 22 (3.76%) samples. Males (61.7%) and patients over 50 years old (75.6%) were more commonly affected than others, and malaise and fatigue (84%), and wheezing (75%) were the most common symptoms, followed by fever (40.48%) and dyspnea (39.51%). Among the Pneumocystis-positive patients, three cases had coinfection with Aspergillus fumigatus, A. flavus, and A. niger (each n = 1), as documented by direct microscopy, culture, and species identification by PCR-sequencing.Conclusion: Pneumocystis pneumonia is still a diagnostic challenge; therefore, additional large-scale studies are needed to clarify the epidemiology of the disease in immunocompromised or COVID-19 patients.
- 6 April 2023
- Published by Frontiers Media SA in Frontiers in Medicine
- Vol. 10, 1148320
Open AccessMolecular and microscopy detection of Pneumocystis jirovecii in hospitalized patients during the COVID-19 pandemic
Introduction: Early detection of Pneumocystis jirovecii as an opportunistic pathogen that may endanger predisposed persons, including COVID-19 patients, may help to choose the optimal management.Methods: In this study, 585, including 530 COVID-19 patients, with clinical and radiological evidence of respiratory diseases, were investigated for P. jirovecii screening. Clinical specimens were examined by direct microscopy and PCR, and randomly selected positive PCR products were confirmed through DNA sequence analysis.Results: Thirty-one (5.3%) samples were positive in P. jirovecii-specific nested-PCR, while by direct microscopic tests, Pneumocystis was observed in 22 (3.76%) samples. Males (61.7%) and patients over 50 years old (75.6%) were more commonly affected than others, and malaise and fatigue (84%), and wheezing (75%) were the most common symptoms, followed by fever (40.48%) and dyspnea (39.51%). Among the Pneumocystis-positive patients, three cases had coinfection with Aspergillus fumigatus, A. flavus, and A. niger (each n = 1), as documented by direct microscopy, culture, and species identification by PCR-sequencing.Conclusion: Pneumocystis pneumonia is still a diagnostic challenge; therefore, additional large-scale studies are needed to clarify the epidemiology of the disease in immunocompromised or COVID-19 patients.